IQVIA Holdings | IQV - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Accenture USD 16.37B 360.32M 2026-03
Agilent USD 1.5B 23M 2026-03
Bruker USD 542.7M 2.2M 2026-03
Cardinal Health USD 13.65B 14M 2026-03
Celltrion KRW 2.01T 39.71B 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Cigna USD 26.61B 6.26B 2026-03
Cognizant Technology Solutions USD 4.61B 170M 2026-03
Computer Programs Systems USD 57.9M 5.82M 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
CVS Health USD 40.99B 1.21B 2026-03
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 622M 66M 2026-03
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Elevance Health USD 22.79B 1.25B 2026-03
Humana USD 5.22B 1.95B 2026-03
IBM USD 24.22B 6.1B 2025-12
Illumina USD 738M 116M 2026-03
Infosys INR 610.37B 270.69B 2025-12
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Laboratory Of America USD 2.45B 189.8M 2026-03
Malin Corporation EUR 500K 300K 2024-12
McKesson USD 27.99B 228M 2026-03
Mettler Toledo International USD 708.21M 70.04M 2026-03
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pharma Mar EUR 51.19M 9.4M 2026-03
Publicis EUR 18.34B 1.92B 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Quest Diagnostics USD 1.59B 179M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Tilray USD 109.07M 2M 2025-09
UnitedHealth USD 26.59B 3.57B 2026-03
Veeva Systems USD 627.77M 682.57M 2026-03
Veradigm USD 175.72M 58.76M 2022-12
Waters USD 1.76B 930.16M 2026-03
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03